General Partner Inc’s AbbVie ABBV Stock Holding History

General Partner Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$535K	Hold	2,044	–	–	0.29%	58
2026 Q2	$514K	Hold	2,044	–	–	0.28%	62
2026 Q1	$445K	Hold	2,044	–	–	0.27%	59
2025 Q4	$467K	Hold	2,044	–	–	0.26%	57
2025 Q3	$473K	Hold	2,044	–	–	0.26%	59
2025 Q2	$379K	Hold	2,044	–	–	0.22%	65
2025 Q1	$428K	Hold	2,044	–	–	0.28%	57
2024 Q4	$363K	Hold	2,044	–	–	0.22%	66
2024 Q3	$404K	Hold	2,044	–	–	0.25%	63
2024 Q2	$351K	Buy	2,044 +2	+0.1%	+$331	0.22%	65
2024 Q1	$372K	Buy	2,042 +1,792	+717%	+$309K	0.23%	67
2023 Q4	$38.7K	Hold	250	–	–	0.03%	94
2023 Q3	$37.3K	Hold	250	–	–	0.03%	97
2023 Q2	$33.7K	Hold	250	–	–	0.03%	100
2023 Q1	$40.4K	Buy	+250	New	+$38.2K	0.04%	99

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

General Partner Inc's ABBV Position: Q3 2026 in Review

General Partner Inc held its AbbVie (ABBV) position steady in Q3 2026 at 2,044 shares worth $535K. The position accounts for 0.29% of the portfolio, ranked #58.

General Partner Inc first reported a position in ABBV in Q1 2023 and has held it in 15 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

General Partner Inc held 2,044 shares of AbbVie worth $535K as of Q3 2026.
General Partner Inc left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.29% of General Partner Inc's portfolio in Q3 2026, its #58 holding.
General Partner Inc first reported a position in AbbVie in Q1 2023 and has held it in 15 quarters since.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on General Partner Inc's 13F filing for Q3 2026, filed 5 Oct 2026.